日本語English简体中文 繁體中文

600332 Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited白云山Shanghai Stock Exchange

7 posts

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (600332) at a glance

Code
600332
Company
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
Local name
白云山
Market
Shanghai Stock Exchange
Share price
CN¥19.74 -0.16 (-0.80%) Oct 27 close

Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (600332) Stock Price HistoryNear a 52-week low

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited closed at CN¥19.74 on Oct 27, 2026, +1.8% over 1 month, −23.1% over 1 year.

2026-10-10 新薬・製品の承認 广州白云山医药集团股份有限公司关于子公司收到药品注册证书的公告 / 対外投資 广州白云山医药集团股份有限公司关于股权投资基金完成管理人变更备案暨关联…2026-10-13 新薬・製品の承認 广州白云山医药集团股份有限公司关于子公司获得药物临床试验批准通…2026-10-14 取締役会 H股公告(董事会召开日期)2026-10-16 新薬・製品の承認 广州白云山医药集团股份有限公司关于子公司药品通过仿制药一致性评…2026-10-27 新薬・製品の承認 广州白云山医药集团股份有限公司关于子公司药物进入II期临床试验的…CN¥20.27CN¥19.40Sep 28Oct 27
Price5-day MA25-day MASSE CompositeDisclosures
1-Month HighCN¥20.27Oct 19
1-Month LowCN¥19.40Sep 29
1-Week Change−0.5%vs Oct 20
1-Month Change+1.8%vs Sep 24

If you had invested CN¥10,000 1 month ago, it would be worth CN¥10,149 today (+1.5%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved −4.6%, while this stock moved +1.5%.

Last 10 Trading Days

DateCloseChange% Change
Oct 27 (Tue)CN¥19.74−0.16−0.80%
Oct 26 (Mon)CN¥19.90+0.32+1.63%
Oct 23 (Fri)CN¥19.58+0.07+0.36%
Oct 22 (Thu)CN¥19.51−0.22−1.12%
Oct 21 (Wed)CN¥19.73−0.11−0.55%
Oct 20 (Tue)CN¥19.84−0.43−2.12%
Oct 19 (Mon)CN¥20.27+0.33+1.65%
Oct 16 (Fri)CN¥19.94+0.05+0.25%
Oct 15 (Thu)CN¥19.89−0.17−0.85%
Oct 14 (Wed)CN¥20.06+0.18+0.91%
2026-09-22 変更届 广州白云山医药集团股份有限公司关于控股股东股权结构变更的提示性公告2026-10-10 新薬・製品の承認 广州白云山医药集团股份有限公司关于子公司收到药品注册证书的公告 / 対外投資 广州白云山医药集团股份有限公司关于股权投资基金完成管理人变更备案暨关联…2026-10-13 新薬・製品の承認 广州白云山医药集团股份有限公司关于子公司获得药物临床试验批准通…2026-10-14 取締役会 H股公告(董事会召开日期)2026-10-16 新薬・製品の承認 广州白云山医药集团股份有限公司关于子公司药品通过仿制药一致性评…2026-10-27 新薬・製品の承認 广州白云山医药集团股份有限公司关于子公司药物进入II期临床试验的…CN¥22.28CN¥19.39Jul 27Oct 27
Price5-day MA25-day MASSE CompositeDisclosures
3-Month HighCN¥22.28Jul 31
3-Month LowCN¥19.39Sep 24
1-Month Change+1.8%vs Sep 24
3-Month Change−9.3%vs Jul 27

If you had invested CN¥10,000 3 months ago, it would be worth CN¥9,068 today (−9.3%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved −5.4%, while this stock moved −9.3%.

Last 10 Trading Days

DateCloseChange% Change
Oct 27 (Tue)CN¥19.74−0.16−0.80%
Oct 26 (Mon)CN¥19.90+0.32+1.63%
Oct 23 (Fri)CN¥19.58+0.07+0.36%
Oct 22 (Thu)CN¥19.51−0.22−1.12%
Oct 21 (Wed)CN¥19.73−0.11−0.55%
Oct 20 (Tue)CN¥19.84−0.43−2.12%
Oct 19 (Mon)CN¥20.27+0.33+1.65%
Oct 16 (Fri)CN¥19.94+0.05+0.25%
Oct 15 (Thu)CN¥19.89−0.17−0.85%
Oct 14 (Wed)CN¥20.06+0.18+0.91%
2026-09-22 変更届 广州白云山医药集团股份有限公司关于控股股东股权结构变更的提示性公告2026-10-10 新薬・製品の承認 广州白云山医药集团股份有限公司关于子公司收到药品注册证书的公告 / 対外投資 广州白云山医药集团股份有限公司关于股权投资基金完成管理人变更备案暨关联…2026-10-13 新薬・製品の承認 广州白云山医药集团股份有限公司关于子公司获得药物临床试验批准通…2026-10-14 取締役会 H股公告(董事会召开日期)2026-10-16 新薬・製品の承認 广州白云山医药集团股份有限公司关于子公司药品通过仿制药一致性评…2026-10-27 新薬・製品の承認 广州白云山医药集团股份有限公司关于子公司药物进入II期临床试验的…CN¥22.96CN¥19.39Apr 27Oct 27
Price25-day MA75-day MASSE CompositeDisclosures
6-Month HighCN¥22.96Apr 28
6-Month LowCN¥19.39Sep 24
3-Month Change−9.3%vs Jul 27
6-Month Change−11.4%vs Apr 27

If you had invested CN¥10,000 6 months ago, it would be worth CN¥8,856 today (−11.4%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved −10.7%, while this stock moved −11.4%.

Monthly Closes

MonthMonth-End CloseMonthly %
Oct 2026CN¥19.74+0.1%
Sep 2026CN¥19.72−3.4%
Aug 2026CN¥20.42−8.3%
Jul 2026CN¥22.28+11.2%
Jun 2026CN¥20.04−6.9%
May 2026CN¥21.52−5.0%
Apr 2026CN¥22.65−0.9%
2026-09-22 変更届 广州白云山医药集团股份有限公司关于控股股东股权结构变更的提示性公告2026-10-10 新薬・製品の承認 广州白云山医药集团股份有限公司关于子公司收到药品注册证书的公告 / 対外投資 广州白云山医药集团股份有限公司关于股权投资基金完成管理人变更备案暨关联…2026-10-13 新薬・製品の承認 广州白云山医药集团股份有限公司关于子公司获得药物临床试验批准通…2026-10-14 取締役会 H股公告(董事会召开日期)2026-10-16 新薬・製品の承認 广州白云山医药集团股份有限公司关于子公司药品通过仿制药一致性评…2026-10-27 新薬・製品の承認 广州白云山医药集团股份有限公司关于子公司药物进入II期临床试验的…CN¥27.37CN¥19.39Oct 27Oct 27
Price25-day MA75-day MASSE CompositeDisclosures
52-Week HighCN¥27.37Nov 11
52-Week LowCN¥19.39Sep 24
Year to Date−23.3%vs Dec 31
From 52-Week High−27.9%Nov 11

If you had invested CN¥10,000 1 year ago, it would be worth CN¥7,687 today (−23.1%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved −8.7%, while this stock moved −23.1%.

Monthly Closes

MonthMonth-End CloseMonthly %
Oct 2026CN¥19.74+0.1%
Sep 2026CN¥19.72−3.4%
Aug 2026CN¥20.42−8.3%
Jul 2026CN¥22.28+11.2%
Jun 2026CN¥20.04−6.9%
May 2026CN¥21.52−5.0%
Apr 2026CN¥22.65−0.9%
Mar 2026CN¥22.86−9.6%
Feb 2026CN¥25.29+0.2%
Jan 2026CN¥25.25−1.9%
Dec 2025CN¥25.74−0.2%
Nov 2025CN¥25.80−2.1%
Oct 2025CN¥26.36―
CN¥32.62CN¥19.39Oct 30, 2023Oct 27, 2026
Price13-week MA26-week MASSE Composite
3-Year HighCN¥32.62May 13, 2024
3-Year LowCN¥19.39Sep 24, 2026
Annualized Return−12.6%
Max Drawdown−40.6%

If you had invested CN¥10,000 3 years ago, it would be worth CN¥6,680 today (−33.2%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved +20.4%, while this stock moved −33.2%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)CN¥19.74−23.3%
2025CN¥25.74―
CN¥35.93CN¥19.39Nov 1, 2021Oct 27, 2026
Price13-week MA26-week MASSE Composite
5-Year HighCN¥35.93May 22, 2023
5-Year LowCN¥19.39Sep 24, 2026
Annualized Return−7.5%
Max Drawdown−46.0%

If you had invested CN¥10,000 5 years ago, it would be worth CN¥6,781 today (−32.2%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved +4.5%, while this stock moved −32.2%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)CN¥19.74−23.3%
2025CN¥25.74―
CN¥45.49CN¥4.11Mar 1, 2001Oct 27, 2026
Price1-year MA2-year MASSE Composite
All-Time HighCN¥45.49Apr 2019
All-Time LowCN¥4.11Mar 2005
Total Change+36.2%vs Mar 2001
Annualized Return+1.2%

If you had invested CN¥10,000 in Mar 2001, it would be worth CN¥13,623 today (+36.2%).Price change only; dividends and fees are not included.

Over the same period the SSE Composite moved +72.7%, while this stock moved +36.2%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)CN¥19.74−23.3%
2025CN¥25.74−9.4%
2024CN¥28.42−0.6%
2023CN¥28.60−4.0%
2022CN¥29.79−12.9%
2021CN¥34.20+16.9%
2020CN¥29.25−17.9%
2019CN¥35.61−0.4%
2018CN¥35.76+11.3%
2017CN¥32.14+34.0%
2016CN¥23.98−20.8%
2015CN¥30.27+11.7%
2014CN¥27.11−2.0%
2013CN¥27.66+42.4%
2012CN¥19.42+47.8%
2011CN¥13.14−36.5%
2010CN¥20.69+82.0%
2009CN¥11.37+93.4%
2008CN¥5.88−66.5%
2007CN¥17.55+127.6%
2006CN¥7.71+23.2%
2005CN¥6.26+42.6%
2004CN¥4.39−33.6%
2003CN¥6.61−23.2%
2002CN¥8.61−26.1%
2001CN¥11.65―

Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Mar 2001). Please check the latest prices before trading.

Recent announcements (CNINFO, in Chinese)

Posts

This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.

No.7 Disclosure 2026/10/27 09:00
新薬・製品の承認
广州白云山医药集团股份有限公司关于子公司药物进入II期临床试验的公告
Delete
No.6 Disclosure 2026/10/16 09:00
新薬・製品の承認
广州白云山医药集团股份有限公司关于子公司药品通过仿制药一致性评价的公告
Delete
No.5 Disclosure 2026/10/14 09:00
取締役会
H股公告(董事会召开日期)
Delete
No.4 Disclosure 2026/10/13 09:00
新薬・製品の承認
广州白云山医药集团股份有限公司关于子公司获得药物临床试验批准通知书的公告
Delete
No.3 Disclosure 2026/10/10 09:00
対外投資
广州白云山医药集团股份有限公司关于股权投资基金完成管理人变更备案暨关联交易进展公告
Delete
No.2 Disclosure 2026/10/10 09:00
新薬・製品の承認
广州白云山医药集团股份有限公司关于子公司收到药品注册证书的公告
Delete
No.1 Disclosure 2026/09/22 09:00
変更届
广州白云山医药集团股份有限公司关于控股股东股权结构变更的提示性公告
Delete

Write on the Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited board

You will need this to delete your post. Please keep it safe.
By posting you agree to the board rules (Japanese). You are responsible for what you write.

More Chinese stocks in English

Chinese Stock Message Board: stocks available in English

Other boards in English